Celanese Corp Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Celanese Corporation on October 25, 2017, regarding an event that occurred on October 23, 2017. The filing addresses a change in the Company's senior executive leadership structure.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to personnel changes and does not contain financial performance data.
Material Changes
The primary material change reported is the departure of Christopher W. Jensen, Executive Vice President and Chief Financial Officer, who is taking a temporary medical leave of absence effective immediately. In his absence, Kevin S. Oliver, the Chief Accounting Officer, will act as the principal financial officer and assume responsibility for finance, tax, and treasury functions.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance, outlook, or management commentary on market conditions. The only risk or contingency noted is the temporary absence of the CFO, which the Company is managing by having other executive officers assume his duties while remaining in their current positions.
Key Facts for Investors to Verify
- Christopher W. Jensen is on temporary medical leave effective October 23, 2017.
- Kevin S. Oliver is serving as the interim principal financial officer.
- The filing contains no financial results or forward-looking guidance.